Trial intelligence / Profile preview

Simvastatin for prevention of postoperative cardiopulmonary complications after oesophagectomy

2015-004424-65Phase 2Unknown

Sponsor
Belfast Health and Social Care Trust
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in postoperative respiratory complications (PRC), acute respiratory distress syndrome (ARDS) and myocardial infarction (MI) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Composite incidence of ARDS, postoperative pulmonary complications, and myocardial infarction. Status: unknown.

02

Drugs

simvastatin
03

Conditions

postoperative respiratory complications (PRC)acute respiratory distress syndrome (ARDS)myocardial infarction (MI)

Beyond the preview

Go deeper on 2015-004424-65.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-004424-65.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call